Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.

Finotello, R; Stefanello, D; Zini, E; Marconato, L

Finotello, R; Stefanello, D; Zini, E; Marconato, L.

Affiliation

Finotello R; Department of Veterinary Clinics, Small Animal Teaching Hospital, University of Pisa, Pisa, Italy.
Stefanello D; Division of Radiation Oncology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Zini E; Department of Veterinary Science and Public Health, University of Milan, Milan, Italy.
Marconato L; Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

Vet Comp Oncol ; 15(1): 25-35, 2017 Mar.

Article in En | MEDLINE | ID: mdl-25623994

Subject(s)

Antibiotics, Antineoplastic/therapeutic use; Antineoplastic Agents, Alkylating/therapeutic use; Cyclophosphamide/therapeutic use; Dacarbazine/therapeutic use; Dog Diseases/drug therapy; Doxorubicin/therapeutic use; Hemangiosarcoma/veterinary; Animals; Dog Diseases/pathology; Dog Diseases/surgery; Dogs; Female; Hemangiosarcoma/drug therapy; Hemangiosarcoma/pathology; Hemangiosarcoma/surgery; Male; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome

Key words

cyclophosphamide; dacarbazine; dog; doxorubicin; hemangiosarcoma

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Antineoplastic Agents, Alkylating / Cyclophosphamide / Dacarbazine / Dog Diseases / Hemangiosarcoma / Antibiotics, Antineoplastic Type of study: Guideline Limits: Animals Language: En Journal: Vet Comp Oncol Journal subject: MEDICINA VETERINARIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google